EGFR and cancer: By increasing ROS production, activating mitochondrial-dependent pathways, blocking EGFR-mediated tyrosine kinase cascades, enhancing p38-MAPK, and blocking the EGFR-mediated tyrosine kinase cascades, targeted bee venom-CSNPs have been discovered to promote cancer cell death.